Isotiorga (Isotretinoin)

Isotretinoin binds to retinoic acid receptors in skin cells, altering gene expression to shrink sebaceous glands, lower sebum production, normalize follicular keratinization, and exert anti‑inflammatory effects. These actions target the primary mechanisms that drive severe acne.

The dosage of isotretinoin is individualized by the prescribing clinician based on body weight, severity of disease, and laboratory parameters. Physicians determine the appropriate daily amount and treatment duration, which typically ranges from several weeks to months.

Isotiorga is classified as Pregnancy Category X because isotretinoin is highly teratogenic. It must not be used by pregnant or nursing women, and effective contraception is required for women of childbearing potential throughout treatment and for a defined period after discontinuation.

To request Isotiorga, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any special handling), and necessary import documentation.

Compared with oral antibiotics, isotretinoin offers a disease‑modifying effect that can produce long‑term remission after a finite course, whereas antibiotics generally require prolonged use and carry resistance concerns. Relative to other retinoids such as acitretin, isotretinoin has a more favorable safety profile for acne but shares similar teratogenic risks.

Isotiorga should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to excessive heat or humidity to maintain potency.

Isotiorga is taken orally, usually with a meal to improve absorption and reduce gastrointestinal irritation. The tablet should be swallowed whole with water; crushing or chewing is not recommended unless specifically instructed by a healthcare professional.

The most critical risks include teratogenicity, severe depression or suicidal thoughts, inflammatory bowel disease, pancreatitis, and marked elevations in triglycerides or liver enzymes. Patients should be monitored closely for mood changes, abdominal pain, and laboratory abnormalities throughout therapy.

Isotiorga is contraindicated in pregnant women, women planning pregnancy, and nursing mothers. It should also be avoided in patients with known hypersensitivity to isotretinoin or other retinoids, those with uncontrolled hyperlipidemia, severe liver disease, or a history of severe psychiatric disorders without appropriate supervision.